Media

Can medical cannabis decrease Arkansas’ opioid deaths?


A study concludes it will take a one-two punch of medical cannabis and prescription drug monitoring programs to decrease opioid-related mortality.


By John Lovett
Times Record

Will implementation of medical cannabis in Arkansas reduce the use of potentially deadly opioid painkillers?

Several medical studies indicate it will, but the conclusion of a recent study published by the National Center for Biotechnology Information concludes it will take a one-two punch of medical cannabis and prescription drug monitoring programs to decrease opioid-related mortality.

That same study, titled “Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality,” also showed opioid-related mortality rate was slower in states with medical cannabis laws than those simply with prescription drug monitoring programs.

The Arkansas Prescription Drug Monitoring Program was amended this year to “mandate prescribers check the prescription drug monitoring program when prescribing certain medications.”

Dr. Joe Goldstrich, an Iowa-based physician who works with those in Arkansas creating medical cannabis guidelines, has become a vocal proponent of cannabis as an alternative to opioids. He says he has seen its benefits first hand: In 2014 at an Oakland, Calif., clinic he saw “a majority of patients reduce opioids to safer levels” and many reduced opioids enough with medical cannabis to completely wean themselves off drugs like oxycontin. Read more.

Rainwater, Hold & Sexton Injury Lawyers 800-434-4800

Guardian Pro RFID and AAC Risk Management Fund mitigate risks for Arkansas jails